N. Kocabasoglu Et Al. , "Venlafaxine versus fluoxetine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12 week, controlled study," 17th Congress of the European-College-of-Neuropsychopharmacology , vol.14, Stockholm, Sweden, 2004
Kocabasoglu, N. Et Al. 2004. Venlafaxine versus fluoxetine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12 week, controlled study. 17th Congress of the European-College-of-Neuropsychopharmacology , (Stockholm, Sweden).
Kocabasoglu, N., Corapcioglu, A., Yargic, I., & Erdogan, A., (2004). Venlafaxine versus fluoxetine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12 week, controlled study . 17th Congress of the European-College-of-Neuropsychopharmacology, Stockholm, Sweden
Kocabasoglu, N Et Al. "Venlafaxine versus fluoxetine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12 week, controlled study," 17th Congress of the European-College-of-Neuropsychopharmacology, Stockholm, Sweden, 2004
Kocabasoglu, N Et Al. "Venlafaxine versus fluoxetine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12 week, controlled study." 17th Congress of the European-College-of-Neuropsychopharmacology , Stockholm, Sweden, 2004
Kocabasoglu, N. Et Al. (2004) . "Venlafaxine versus fluoxetine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12 week, controlled study." 17th Congress of the European-College-of-Neuropsychopharmacology , Stockholm, Sweden.
@conferencepaper{conferencepaper, author={N Kocabasoglu Et Al. }, title={Venlafaxine versus fluoxetine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12 week, controlled study}, congress name={17th Congress of the European-College-of-Neuropsychopharmacology}, city={Stockholm}, country={Sweden}, year={2004}}